To request article copies, email us at This email address is being protected from spambots. You need JavaScript enabled to view it..


Keshishian A, Boytsov N, Burge R, Krohn K, Lombard L, Zhang X, Xie L, Baser O. Examining the impact of medication adherence on risk of subsequent fracture among women with a fragility fracture in the US Medicare population. J Manag Care Pharm. 2017;28(8):2485-2494.

Keshishian A, Boytsov N, Burge R, Krohn K, Lombard L, Zhang X, Xie L, Baser O. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population. Osteoporos Int. 2017;28(8):2485-2494.

Knight T, Bond C, Popelar B, Wang L, Niewoehner J, Anastassopoulos K, Philbin M. Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab. Clinicoecon Outcomes Res. 2017;9:271-79.  

Kaya B, Yilmaz B, Ekiz F, Altınbas A, Aktas B. Ertapenem induced hyperbilirubinemia. Clin Res Hepatol Gastroenterol. 2015;39(1):e11.

Zedler B, Xie L,  Wang L, Joyce A, Vick C, Brigham J, Kariburyo MF, Baser O, Murrelle L. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans’ Health Administration patients. Pain Med. 2015;16(8):1566-79.

Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15(11):1911-29.

Borah B, Naessens J, Olsen K, Shah ND. Explaining obesity- and smoking-related healthcare costs through unconditional quantile regression. JHEOR. 2013;1(1):23-41.

Kim JY, Asrani SK, Shah ND, Kim WR, Schneekloth TD. Hospitalization for underage drinkers in the United States. J Adolesc Health. 2012;50(6):648-50.

Moriarty JP, Branda ME, Olsen KD, Shah ND, et al. The effects of incremental costs of smoking and obesity on health care costs among adults: A 7-year longitudinal study. J Occup Environ Med. 2012;54(3):286-91.

Chung K, Shauver MJ, Yin H, Kim M, Baser O, Birkmeyer JD. National variations in the utilization of internal fixation techniques for distal radius fracture in the United States Medicare population. J Bone Joint Surg Am. 2011;93(23)2154-62.

Montori VM, Shah ND, Pencille LJ, et al. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med. 2011;124(6):549-56.

Scoville EA, Ponce de Leon Lovaton P, Shah ND, et al. Why do women reject bisphosphonates for osteoporosis? A videographic study. PLoS One. 2011;6(4):e18468.

Thompson JM, Luedtke CA, Oh TH, Shah ND, et al. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011;90(1):40-6.

Pencille LJ, Campbell ME, Van Houten HK, Shah ND, et al. Protocol for the osteoporosis choice trial. A pilot randomized trial of a decision aid in primary care practice. [published online ahead of print December 10 2009]. Trials. 2009;10:113.

Foley K, Foster SA, Meadows ES, Baser O, Long SR. Assessment of clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure. Med Care. 2007;45(9):902-6.

Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis. Blood. 2007;110(7):2331-3.

Dworking RH, White R, O’Connor AB, Baser O, Hawkins K. The spectrum of health care costs associated with herpes zoster: acute pain vs. postherpetic neuralgia. J Am Geriatr Soc. 2007;55(8):1168-75.

Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol. 2007;7(5):387-92.

Akin C. Guest Editor. Mast cells and mastocytosis. Immunol Allergy Clin N Am. 2006;26(3).

Kirshenbaum AS, Akin C, Goff JP, Metcalfe DD. Thrombopoietin alone or in the presence of stem cell factor supports the growth of Kit(CD117)low/MPL(CD110)+ human mast cells from hematopoietic progenitor cells. Exp Hematol. 2005;33:413-21.

Brockow K, Akin C, Huber M, Scott LM, Schwartz LB, Metcalfe DD. Levels of mast cell growth factors in plasma and in suction blister fluid in adults with mastocytosis: correlation with dermal mast cell numbers and mast cell tryptase. J Allergy Clin Immunol. 2002;109:82-8.

Daley T, Metcalfe DD, Akin C. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin. Blood. 2001;98:880-82.

Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD. Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol. 2001;21:171-74.

Taylor ML, Dastych J, Sehgal D, Sundstrom M, Nilsson G, Akin C, et al. The c-KIT activating mutation D816V enhances stem cell factor-dependent chemotaxis. Blood. 2001;98:1195-99.

Akin C, Sonnenfeld G.  Stimulation of granulocyte-macrophage colony stimulating factor (GM-CSF) production and its role as an autocrine inducer of CD14 upregulation in human myeloid leukemia cells. J Interferon Cytokine Res. 1996;16:479-86.

Miller ES, Klinger JC, Akin C, Koebel A, Sonnenfeld G. Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-D-glucose-induced metabolic stress. J Neuroimmunol. 1994;52:165-73.

To request article copies, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it..